VentriPoint Diagnostics Ltd. (VPTDF)
USD 0.11
(-11.72%)
USD 0.11
(-11.72%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 274.37 Thousand CAD | -40.23% |
| 2022 | 459.07 Thousand CAD | 186.98% |
| 2021 | 159.96 Thousand CAD | -88.32% |
| 2020 | 1.36 Million CAD | 21.75% |
| 2019 | 1.12 Million CAD | 0.0% |
| 2018 | - CAD | 0.0% |
| 2017 | - CAD | -100.0% |
| 2016 | 597.12 Thousand CAD | -0.21% |
| 2015 | 598.35 Thousand CAD | -28.05% |
| 2014 | 831.64 Thousand CAD | -58.07% |
| 2013 | 1.98 Million CAD | 46.01% |
| 2012 | 1.35 Million CAD | -25.46% |
| 2011 | 1.82 Million CAD | 8.82% |
| 2010 | 1.67 Million CAD | -14.63% |
| 2009 | 1.96 Million CAD | 145.55% |
| 2008 | 798.98 Thousand CAD | 0.0% |
| 2007 | - CAD | 0.0% |
| 2006 | - CAD | 0.0% |
| 2005 | - CAD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.1 Million CAD | 362.26% |
| 2024 Q1 | 261.23 Thousand CAD | -4.79% |
| 2023 Q2 | 441.45 Thousand CAD | -3.89% |
| 2023 FY | 274.37 Thousand CAD | -40.23% |
| 2023 Q4 | 274.37 Thousand CAD | -35.98% |
| 2023 Q3 | 428.57 Thousand CAD | -2.92% |
| 2023 Q1 | 459.29 Thousand CAD | 0.05% |
| 2022 Q1 | 152.29 Thousand CAD | -4.8% |
| 2022 Q4 | 459.07 Thousand CAD | 232.32% |
| 2022 Q2 | 144.54 Thousand CAD | -5.08% |
| 2022 Q3 | 138.14 Thousand CAD | -4.43% |
| 2022 FY | 459.07 Thousand CAD | 186.98% |
| 2021 Q2 | 204.83 Thousand CAD | -4.86% |
| 2021 FY | 159.96 Thousand CAD | -88.32% |
| 2021 Q4 | 159.96 Thousand CAD | -17.67% |
| 2021 Q3 | 194.29 Thousand CAD | -5.14% |
| 2021 Q1 | 215.29 Thousand CAD | -84.28% |
| 2020 Q1 | 1.15 Million CAD | 2.25% |
| 2020 Q4 | 1.36 Million CAD | 39.55% |
| 2020 Q2 | 1.39 Million CAD | 21.32% |
| 2020 FY | 1.36 Million CAD | 21.75% |
| 2020 Q3 | 981.62 Thousand CAD | -29.67% |
| 2019 Q3 | 811.38 Thousand CAD | -12.8% |
| 2019 Q4 | 1.12 Million CAD | 38.67% |
| 2019 Q1 | 988.67 Thousand CAD | 0.0% |
| 2019 FY | 1.12 Million CAD | 0.0% |
| 2019 Q2 | 930.47 Thousand CAD | -5.89% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2017 FY | - CAD | -100.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q1 | - CAD | -100.0% |
| 2016 Q1 | 540.1 Thousand CAD | -9.73% |
| 2016 FY | 597.12 Thousand CAD | -0.21% |
| 2016 Q4 | 597.12 Thousand CAD | -15.61% |
| 2016 Q3 | 707.54 Thousand CAD | 9.37% |
| 2016 Q2 | 646.9 Thousand CAD | 19.77% |
| 2015 Q1 | 1.06 Million CAD | 27.7% |
| 2015 Q2 | 1.17 Million CAD | 10.67% |
| 2015 Q3 | 665.07 Thousand CAD | -43.41% |
| 2015 FY | 598.35 Thousand CAD | -28.05% |
| 2015 Q4 | 598.35 Thousand CAD | -10.03% |
| 2014 Q2 | 903.77 Thousand CAD | -55.42% |
| 2014 Q1 | 2.02 Million CAD | 2.22% |
| 2014 FY | 831.64 Thousand CAD | -58.07% |
| 2014 Q4 | 831.64 Thousand CAD | 11.66% |
| 2014 Q3 | 744.77 Thousand CAD | -17.59% |
| 2013 FY | 1.98 Million CAD | 46.01% |
| 2013 Q4 | 1.98 Million CAD | -10.78% |
| 2013 Q3 | 2.22 Million CAD | 32.99% |
| 2013 Q2 | 1.67 Million CAD | 20.39% |
| 2013 Q1 | 1.38 Million CAD | 2.21% |
| 2012 FY | 1.35 Million CAD | -25.46% |
| 2012 Q4 | 1.35 Million CAD | 2.32% |
| 2012 Q1 | 1.33 Million CAD | -26.54% |
| 2012 Q3 | 1.32 Million CAD | 3.49% |
| 2012 Q2 | 1.28 Million CAD | -4.18% |
| 2011 Q2 | 1.84 Million CAD | 8.39% |
| 2011 Q4 | 1.82 Million CAD | 1.28% |
| 2011 FY | 1.82 Million CAD | 8.82% |
| 2011 Q1 | 1.7 Million CAD | 1.69% |
| 2011 Q3 | 1.79 Million CAD | -2.52% |
| 2010 Q4 | 1.67 Million CAD | -8.37% |
| 2010 Q3 | 1.82 Million CAD | 6.45% |
| 2010 FY | 1.67 Million CAD | -14.63% |
| 2010 Q2 | 1.71 Million CAD | -9.57% |
| 2010 Q1 | 1.89 Million CAD | -3.21% |
| 2009 FY | 1.96 Million CAD | 145.55% |
| 2009 Q3 | 1.96 Million CAD | 3.79% |
| 2009 Q1 | 1.5 Million CAD | 88.3% |
| 2009 Q2 | 1.88 Million CAD | 25.54% |
| 2009 Q4 | 1.96 Million CAD | 0.08% |
| 2008 Q2 | - CAD | 0.0% |
| 2008 Q3 | - CAD | 0.0% |
| 2008 FY | 798.98 Thousand CAD | 0.0% |
| 2008 Q4 | 798.98 Thousand CAD | 0.0% |
| 2008 Q1 | - CAD | 0.0% |
| 2007 FY | - CAD | 0.0% |
| 2007 Q4 | - CAD | -100.0% |
| 2007 Q3 | 75.96 Thousand CAD | 0.0% |
| 2007 Q2 | - CAD | 0.0% |
| 2007 Q1 | - CAD | 0.0% |
| 2006 Q4 | - CAD | 0.0% |
| 2006 Q3 | - CAD | 0.0% |
| 2006 Q1 | - CAD | 0.0% |
| 2006 FY | - CAD | 0.0% |
| 2006 Q2 | - CAD | 0.0% |
| 2005 FY | - CAD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| QHSLab, Inc. | 1.78 Million USD | 84.599% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Aurora Spine Corporation | 2.67 Million USD | 89.726% |
| ADM Tronics Unlimited, Inc. | 799.65 Thousand USD | 65.688% |
| Avitar, Inc. | 5.26 Million USD | 94.789% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 524.71 Thousand USD | 47.71% |
| Manhattan Scientifics, Inc. | 60 Thousand USD | -357.297% |
| Össur hf. | 467.73 Million USD | 99.941% |
| Össur hf. | 467.73 Million USD | 99.941% |
| CVR Medical Corp. | - USD | -Infinity% |
| Stratec SE | 156.16 Million USD | 99.824% |
| Vycor Medical, Inc. | 1.11 Million USD | 75.287% |
| BrainsWay Ltd. | 471 Thousand USD | 41.746% |
| Kelyniam Global, Inc. | 496.39 Thousand USD | 44.726% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| Positron Corporation | 1.78 Million USD | 84.65% |
| Wellstar International, Inc. | 51.36 Million USD | 99.466% |
| Vivos Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | 4.21 Million USD | 93.491% |
| Heart Tronics, Inc. | 209.28 Thousand USD | -31.103% |
| REMSleep Holdings, Inc. | 178.11 Thousand USD | -54.046% |
| AVITA Medical, Inc. | 449.48 Thousand USD | 38.957% |
| Theraclion SA | 1.95 Million EUR | 85.935% |
| Hamilton Thorne Ltd. | 27.81 Million USD | 99.013% |
| BioElectronics Corporation | 14.83 Million USD | 98.15% |
| Zecotek Photonics Inc. | 3.22 Million USD | 91.484% |
| EKF Diagnostics Holdings plc | 5.21 Million USD | 94.742% |
| Nanomix Corporation | 11.4 Million USD | 97.594% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 4.04 Million USD | 93.212% |
| NewCardio, Inc. | 3 Million USD | 90.854% |
| Electromedical Technologies, Inc. | 1.69 Million USD | 83.846% |
| Lombard Medical, Inc. | 32.29 Million USD | 99.15% |
| ALR Technologies Inc. | 19.26 Million USD | 98.576% |
| Nu-Med Plus, Inc. | 100 Thousand USD | -174.378% |
| MicroPort Scientific Corporation | 1.69 Billion USD | 99.984% |
| VMS Rehab Systems, Inc. | 133.52 USD | -205395.806% |
| Guided Therapeutics, Inc. | 2.05 Million USD | 86.668% |
| Ingen Technologies, Inc. | 631.15 Thousand USD | 56.528% |
| CYduct Diagnostics, Inc. | 670 Thousand USD | 59.048% |
| Odyssey Group International, Inc. | 2.14 Million USD | 87.206% |
| SANUWAVE Health, Inc. | 31.94 Million USD | 99.141% |
| IR-Med Inc. | 161 Thousand USD | -70.421% |
| Perimeter Medical Imaging AI, Inc. | 192.89 Thousand USD | -42.243% |
| United American Healthcare Corporation | - USD | -Infinity% |
| Polarean Imaging plc | 216.38 Thousand USD | -26.801% |
| ECGI Holdings, Inc. | 3.17 Million USD | 91.348% |
| Capital Group Holdings, Inc. | 4944.00 USD | -5449.717% |
| Medical Supply International USA, Inc. | 227 Thousand USD | -20.87% |
| Rapid Therapeutic Science Laboratories, Inc. | 3.83 Million USD | 92.837% |
| SS Innovations International, Inc. | 8.21 Million USD | 96.661% |
| Urologix, Inc. | 5.33 Million USD | 94.855% |
| Qualis Innovations, Inc. | 9102.00 USD | -2914.48% |
| Smith & Nephew plc | 3.07 Billion USD | 99.991% |
| NIOX Group Plc | 1.4 Million USD | 80.406% |
| Fuse Medical, Inc. | 1.99 Million USD | 86.237% |
| Broncus Holding Corporation | 2.35 Million USD | 88.346% |
| Brain Scientific Inc. | 2.86 Million USD | 90.418% |
| Pressure BioSciences, Inc. | 22.75 Million USD | 98.794% |
| Health Logic Interactive Inc. | 40.44 Thousand USD | -578.448% |